1. Home
  2. LYRA vs RVSN Comparison

LYRA vs RVSN Comparison

Compare LYRA & RVSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • RVSN
  • Stock Information
  • Founded
  • LYRA 2005
  • RVSN 2016
  • Country
  • LYRA United States
  • RVSN Israel
  • Employees
  • LYRA N/A
  • RVSN N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • RVSN
  • Sector
  • LYRA Health Care
  • RVSN
  • Exchange
  • LYRA Nasdaq
  • RVSN Nasdaq
  • Market Cap
  • LYRA 5.8M
  • RVSN 6.6M
  • IPO Year
  • LYRA 2020
  • RVSN 2022
  • Fundamental
  • Price
  • LYRA $24.28
  • RVSN $0.39
  • Analyst Decision
  • LYRA Buy
  • RVSN
  • Analyst Count
  • LYRA 2
  • RVSN 0
  • Target Price
  • LYRA $100.00
  • RVSN N/A
  • AVG Volume (30 Days)
  • LYRA 1.9M
  • RVSN 442.3K
  • Earning Date
  • LYRA 05-06-2025
  • RVSN 06-17-2025
  • Dividend Yield
  • LYRA N/A
  • RVSN N/A
  • EPS Growth
  • LYRA N/A
  • RVSN N/A
  • EPS
  • LYRA N/A
  • RVSN N/A
  • Revenue
  • LYRA $1,185,000.00
  • RVSN $1,300,000.00
  • Revenue This Year
  • LYRA N/A
  • RVSN $1,861.54
  • Revenue Next Year
  • LYRA $1,286.17
  • RVSN N/A
  • P/E Ratio
  • LYRA N/A
  • RVSN N/A
  • Revenue Growth
  • LYRA N/A
  • RVSN 815.49
  • 52 Week Low
  • LYRA $3.81
  • RVSN $0.27
  • 52 Week High
  • LYRA $37.50
  • RVSN $2.72
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 76.38
  • RVSN 48.38
  • Support Level
  • LYRA $22.22
  • RVSN $0.36
  • Resistance Level
  • LYRA $27.42
  • RVSN $0.40
  • Average True Range (ATR)
  • LYRA 4.12
  • RVSN 0.02
  • MACD
  • LYRA 2.36
  • RVSN -0.00
  • Stochastic Oscillator
  • LYRA 60.76
  • RVSN 43.43

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About RVSN Rail Vision Ltd.

Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.

Share on Social Networks: